Your browser doesn't support javascript.
loading
Cov2MS: An Automated and Quantitative Matrix-Independent Assay for Mass Spectrometric Measurement of SARS-CoV-2 Nucleocapsid Protein.
Van Puyvelde, Bart; Van Uytfanghe, Katleen; Van Oudenhove, Laurence; Gabriels, Ralf; Van Royen, Tessa; Matthys, Arne; Razavi, Morteza; Yip, Richard; Pearson, Terry; Drouin, Nicolas; Claereboudt, Jan; Foley, Dominic; Wardle, Robert; Wyndham, Kevin; Hankemeier, Thomas; Jones, Donald; Saelens, Xavier; Martens, Geert; Stove, Christophe P; Deforce, Dieter; Martens, Lennart; Vissers, Johannes P C; Anderson, N Leigh; Dhaenens, Maarten.
Afiliación
  • Van Puyvelde B; ProGenTomics, Laboratory of Pharmaceutical Biotechnology, Ghent University, 9000 Ghent, Belgium.
  • Van Uytfanghe K; Laboratory of Toxicology, Department of Bioanalysis, Faculty of Pharmaceutical Sciences, Ghent University, 9000 Ghent, Belgium.
  • Van Oudenhove L; Waters Corporation, 2600 Antwerp, Belgium.
  • Gabriels R; VIB-UGent Center for Medical Biotechnology, VIB, 9000 Ghent, Belgium.
  • Van Royen T; Department of Biomolecular Medicine, Ghent University, 9000 Ghent, Belgium.
  • Matthys A; VIB-UGent Center for Medical Biotechnology, VIB, 9000 Ghent, Belgium.
  • Razavi M; Department of Biochemistry and Microbiology, Ghent University, Ghent 9000 Belgium.
  • Yip R; VIB-UGent Center for Medical Biotechnology, VIB, 9000 Ghent, Belgium.
  • Pearson T; Department of Biochemistry and Microbiology, Ghent University, Ghent 9000 Belgium.
  • Drouin N; SISCAPA Assay Technologies, Inc., Box 53309, Washington, DC 20009, United States.
  • Claereboudt J; Department of Biochemistry and Microbiology, University of Victoria, Victoria, BC V8P 5C2, Canada.
  • Foley D; SISCAPA Assay Technologies, Inc., Box 53309, Washington, DC 20009, United States.
  • Wardle R; Department of Biochemistry and Microbiology, University of Victoria, Victoria, BC V8P 5C2, Canada.
  • Wyndham K; SISCAPA Assay Technologies, Inc., Box 53309, Washington, DC 20009, United States.
  • Hankemeier T; Department of Biochemistry and Microbiology, University of Victoria, Victoria, BC V8P 5C2, Canada.
  • Jones D; Division of Systems Biomedicine and Pharmacology, Leiden Academic Centre for Drug Research, Leiden University, 2333 AL Leiden, The Netherlands.
  • Saelens X; Waters Corporation, 2600 Antwerp, Belgium.
  • Martens G; Waters Corporation, Wilmslow SK9 4AX, United Kingdom.
  • Stove CP; Waters Corporation, Milford, Massachusetts 01757, United States.
  • Deforce D; Waters Corporation, Wilmslow SK9 4AX, United Kingdom.
  • Martens L; Waters Corporation, Milford, Massachusetts 01757, United States.
  • Vissers JPC; Waters Corporation, Wilmslow SK9 4AX, United Kingdom.
  • Anderson NL; Waters Corporation, Milford, Massachusetts 01757, United States.
  • Dhaenens M; Division of Systems Biomedicine and Pharmacology, Leiden Academic Centre for Drug Research, Leiden University, 2333 AL Leiden, The Netherlands.
Anal Chem ; 94(50): 17379-17387, 2022 12 20.
Article en En | MEDLINE | ID: mdl-36490367
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Anal Chem Año: 2022 Tipo del documento: Article País de afiliación: Bélgica
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Anal Chem Año: 2022 Tipo del documento: Article País de afiliación: Bélgica